CAPRICORN and COPERINUS studies
Juillière, Y.
Archives des Maladies du Coeur et des Vaisseaux 95 Spec 4(5 Spec 4: 17-20
2002
ISSN/ISBN: 0003-9683 PMID: 11933550 Document Number: 549571
The CAPRICORN and COPERNICUS studies have confirmed the significance of betablocker treatment with carvedilol for indications which this medication did not yet possess: post-infarction with left ventricular dysfunction with or without clinical signs, and stable severe cardiac insufficiency. The reduction in morbidity and mortality obtained thanks to this therapy places it in the treatment of cardiac insufficiency in association with the angiotensin converting enzyme inhibitors which remain unsurpassed.